Addressing hepatitis

World hepatitis day exhibition in Mandalay, 29 July 2017

Viral Hepatitis is a major cause of liver cancer and cirrhosis, contributing to premature morbidity and mortality, and undermining economic growth and the push to achieve health and wellbeing for all.

In Myanmar, National Hepatitis Control Programme was established in late 2014 with the strong collaborative effort of MoHS, WHO, Liver foundation, local NGOs and INGOs. Viral hepatitis prevention and control activities are strengthened in Myanmar since 2014. Furthermore, hepatitis C treatment with oral, direct acting antivirals is being pioneered, since June 2017, in designated hospitals at Yangon, Mandalay and Nay Pyi Taw.

Since 2011, WHO has been collaborating with the World Hepatitis Alliance to coordinate the annual campaign for World Hepatitis day (WHD). The 7th WHD commemorated on 28th July 2017 was to highlight the collective efforts being made towards the elimination of hepatitis as a public health threat by 2030. This year provides a great opportunity for Myanmar to campaign to “Eliminate hepatitis”.

World Hepatitis day 2017 was observed in several parts of the country. For instance, Mandalay on 29 July 2017 and Taunggyi on 5 August 2017. During commemorations, the health sector organized educational talks, exhibitions and testing for viral hepatitis B and C.